Frontier Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $25.8M | Buy |
|
|||||
|
2023
Q3 | $15.8M | Buy |
|
|||||
|
2023
Q2 | $15.6M | Buy |
|
|||||
|
2023
Q1 | $10.1M | Buy |
|
|||||
|
2022
Q4 | $5.75M | Sell |
|
|||||
|
2022
Q3 | $7.93M | Sell |
|
|||||
|
2022
Q2 | $7.98M | Sell |
|
|||||
|
2022
Q1 | $21.3M | Sell |
|
|||||
|
2021
Q4 | $24.7M | Buy |
|
|||||
|
2021
Q3 | $6.47M | Sell |
|
|||||
|
2021
Q2 | $25.5M | Buy |
|
|||||
|
2021
Q1 | $11.9M | Sell |
|
|||||
|
2020
Q4 | $51.3M | Sell |
|
|||||
|
2020
Q3 | $41M | Sell |
|
|||||
|
2020
Q2 | $57.5M | Sell |
|
|||||
|
2020
Q1 | $57.3M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $6.5M | Buy |
|
|||||
|
2017
Q4 | $2.64M | Sell |
|
|||||
|
2017
Q3 | $15.3M | Sell |
|
|||||
|
2017
Q2 | $18.7M | Buy |
|
|||||
|
2017
Q1 | $21.9M | Buy |
|
|||||
|
2016
Q4 | $10.8M | Sell |
|
|||||
|
2016
Q3 | $20.2M | Buy |
|
|||||
|
2016
Q2 | $8.8M | Sell |
|
|||||
|
2016
Q1 | $7.89M | Sell |
|
|||||
|
2015
Q4 | $12.3M | Buy |
|